Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Catalent Pharma Solutions, LLC | Novo Holdings A/S | wage and hour violation | 2010 | WHD | $17,160 |
Synthes Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $15,000 |
Novartis Corporation | Novartis | employment discrimination | 2010 | private lawsuit-federal | $175,000,000 |
Sanofi-Aventis U.S. LLC | Sanofi | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2010 | private lawsuit-federal | $8,500,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Allergan Inc. | AbbVie | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $600,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249 |
Elan Corp. | Perrigo | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
GlaxoSmithKline | GSK plc | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline LLC | GSK plc | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
Merck Sharp & Dohme Corp | Merck | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Purepac Pharmaceutical Co. | Pfizer | False Claims Act and related | 2010 | ID-AG | $600,000 |
Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
SB Pharmco Puerto Rico Inc. | GSK plc | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Phibro-Tech Inc. | Phibro Animal Health | hazardous waste violation | 2010 | CA-DTSC | $39,000 |
Pfizer, Inc. | Pfizer | environmental violation | 2010 | CT-ENV | $31,266 |
CATALENT PHARMA SOLUTIONS, LLC | Novo Holdings A/S | air pollution violation | 2010 | KY-ENV | $65,000 |
MERCK SHARP & DOHME CORP | Merck | hazardous waste violation | 2010 | NJ-ENV | $8,000 |
MERCK SHARP & DOHME CORP - RAHWAY NJ | Merck | air pollution violation | 2010 | NJ-ENV | $6,000 |
AstraZeneca | AstraZeneca | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
GlaxoSmithKline | GSK plc | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $41,500,000 |
Purdue Pharma L.P. | Purdue Pharma | price-fixing or anti-competitive practices | 2010 | private lawsuit-federal | $16,000,000 |
Solvay Pharmaceuticals Inc. | AbbVie | consumer protection violation | 2010 | private lawsuit-federal | $16,500,000 |
SCHWARZ PHARMA MANUFACTURING, INC. | UCB | workplace safety or health violation | 2010 | OSHA | $6,750 |
EISAI INC. | Eisai | workplace safety or health violation | 2010 | OSHA | $6,376 |
COVIDIEN DBA MALLINCKRODT INC. | Mallinckrodt | workplace safety or health violation | 2010 | OSHA | $41,613 |
MILLIPORE CORP | Merck KGaA (EMD) | environmental violation | 2010 | EPA | $526,500 |
Wyeth Pharmaceuticals Company, Inc. | Pfizer | environmental violation | 2010 | EPA | $77,000 |
Schering Plough Products, LLC | Merck | environmental violation | 2010 | EPA | $11,500 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | environmental violation | 2010 | EPA | $105,000 |
Pfizer Pharmaceuticals | Pfizer | environmental violation | 2010 | EPA | $24,650 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
St Jude Medical Inc | Abbott Laboratories | wage and hour violation | 2009 | WHD | $17,662 |
Abbott Laboratories Puerto Rico, Inc. | Abbott Laboratories | wage and hour violation | 2009 | WHD | $49,045 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Merck and Company, Inc. | Merck | labor relations violation | 2009 | NLRB | $10,710 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
Pfizer | Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |